Figure 1.
LC3 expression by immunohistochemistry in resected hepatocellular carcinoma (HCC).
Representative images of areas according to the proportion of positive cells (A–D) and intensity of staining (E–H). (A) none, (B) < 10%, (C) 10–50%, (D) > 50%; and staining (E) absent, (F) weak, (G) moderate, (H) strong. (LC3 stain, ×100) (upper panel, X 200; lower panel, X 400).
Figure 2.
Kaplan–Meier survival analysis of LC3 expression in hepatocellular carcinoma (HCC) patients according to stage.
LC3 expression in HCC patients with (A) early (I,II) and (B) advanced TNM stage (III), (C) early (I, II) and (D) advanced Edmondson-Steiner Grades (III, IV), (E) early (0,A) and (F) advanced BCLC stages (B,C). The p - value calculated by the log-rank test is indicated.
Figure 3.
Kaplan–Meier curves of time to recurrence in hepatocellular carcinoma patients.
LC3 positive group (n = 40) and LC3 negative group (n = 150).